Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.
A CRISPR screen reveals a potential combination therapy for relapsed neuroblastoma.
St. Jude Global helps provide a framework for rebuilding health care capacity after a crisis.
Explore how tumor-associated macrophages shape CAR T-cell therapy efficacy in high-grade gliomas.
Meet St. Jude senior scientist Alaa Refaat, PhD, and learn about his work to develop treatments for childhood brain tumors using chemical biology approaches.
Discover how disruption ribosomes creation provides promise for “undruggable” cancers.
See how Aseem Ansari's SynGRs target BET proteins, offering potential for treating diseases like Friedreich’s ataxia and advancing BET domain understanding
Follow the path of illustrious speakers that have spoken at St. Jude’s keystone lecture series.
Follow Christy LaFlamme in her graduate school journey.
Catch up on the series St. Jude On Biology in Space & Time with 5 Discoveries to Explore.